Shaochuan Liu

499 total citations
15 papers, 362 citations indexed

About

Shaochuan Liu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Shaochuan Liu has authored 15 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Shaochuan Liu's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Shaochuan Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Shaochuan Liu collaborates with scholars based in China, United States and Netherlands. Shaochuan Liu's co-authors include Tingting Qin, Kai Li, Yanan Jia, Zhujun Liu, Jing Wang, Yuan Gao, Xiubao Ren, Qian Sun, Wenwen Yu and Hailin Liu and has published in prestigious journals such as Advanced Science, Journal of Leukocyte Biology and Cell Death and Disease.

In The Last Decade

Shaochuan Liu

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaochuan Liu China	9	237	121	106	89	54	15	362
Francesca Sparano Italy	9	219 0.9×	78 0.6×	113 1.1×	103 1.2×	65 1.2×	19	369
Adrien Costantini France	10	279 1.2×	95 0.8×	120 1.1×	146 1.6×	73 1.4×	25	402
Yaqun Li China	5	182 0.8×	113 0.9×	106 1.0×	58 0.7×	36 0.7×	10	320
Louqian Zhang China	11	147 0.6×	106 0.9×	149 1.4×	139 1.6×	53 1.0×	23	406
Giacomo Barchiesi Italy	11	232 1.0×	84 0.7×	108 1.0×	96 1.1×	88 1.6×	22	376
Bożena Cybulska-Stopa Poland	11	246 1.0×	81 0.7×	102 1.0×	73 0.8×	25 0.5×	58	330
Xiao Zhao China	9	202 0.9×	67 0.6×	84 0.8×	130 1.5×	41 0.8×	29	323
Guangyu An China	13	260 1.1×	115 1.0×	106 1.0×	142 1.6×	54 1.0×	24	416
Emanuela Romagnoli Italy	7	188 0.8×	105 0.9×	90 0.8×	85 1.0×	56 1.0×	16	279
Amy Sullivan United States	6	258 1.1×	124 1.0×	110 1.0×	160 1.8×	87 1.6×	16	380

Countries citing papers authored by Shaochuan Liu

Since Specialization

Citations

This map shows the geographic impact of Shaochuan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaochuan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaochuan Liu more than expected).

Fields of papers citing papers by Shaochuan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaochuan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaochuan Liu. The network helps show where Shaochuan Liu may publish in the future.

Co-authorship network of co-authors of Shaochuan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaochuan Liu. A scholar is included among the top collaborators of Shaochuan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaochuan Liu. Shaochuan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Liu, Shaochuan, Gen Liu, Yong Guan, et al.. (2025). CK2B Induces CD8⁺ T‐Cell Exhaustion through HDAC8‐Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti‐PD‐1 Therapy in Non‐Small‐Cell Lung Cancer. Advanced Science. 12(16). e2411053–e2411053. 6 indexed citations

Zhao, Hua, Shaochuan Liu, Wenwen Yu, et al.. (2024). Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials. Journal of Leukocyte Biology. 116(3). 544–554. 3 indexed citations

Zhang, Dong, Min Wang, Min Liu, et al.. (2024). Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages. Cancer Gene Therapy. 31(7). 1018–1033. 3 indexed citations

Li, Junyi, Yuanjie Cao, Yan‐Cheng Liu, et al.. (2024). Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer. Journal for ImmunoTherapy of Cancer. 12(1). e008355–e008355. 22 indexed citations

Liu, Shaochuan, et al.. (2023). Immune‐independent acquired resistance to PD‐L1 antibody initiated by PD‐L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib. Cancer Medicine. 12(14). 15337–15349. 8 indexed citations

Liu, Shaochuan, Qian Sun, & Xiubao Ren. (2023). Novel strategies for cancer immunotherapy: counter-immunoediting therapy. Journal of Hematology & Oncology. 16(1). 38–38. 53 indexed citations

Liu, Shaochuan, Yuan Meng, Liang Liu, et al.. (2022). Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer. Cancer Gene Therapy. 30(2). 277–287. 7 indexed citations

Liu, Zhujun, Tingting Qin, Xiaohan Yuan, et al.. (2022). Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab. Frontiers in Oncology. 12. 875888–875888. 3 indexed citations

Liu, Shaochuan, Yuan Meng, Liang Liu, et al.. (2022). CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer. Cell Death and Disease. 13(5). 441–441. 33 indexed citations

10.

Li, Baihui, Ziqi Huang, Wenwen Yu, et al.. (2021). Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma. Neoplasia. 23(7). 704–717. 11 indexed citations

11.

Qin, Tingting, Zhujun Liu, Jing Wang, et al.. (2020). Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling. Cancer Biology and Medicine. 17(3). 753–767. 32 indexed citations

12.

Liu, Shaochuan, Tingting Qin, Zhujun Liu, et al.. (2020). anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells. Cell Death and Disease. 11(5). 309–309. 142 indexed citations

13.

Qin, Tingting, Shaochuan Liu, Jing Wang, et al.. (2020). Clinical importance of VEGFC and PD‐L1 co‐expression in lung adenocarcinoma patients. Thoracic Cancer. 11(5). 1139–1148. 8 indexed citations

14.

Liu, Shaochuan, Tingting Qin, Yanan Jia, & Kai Li. (2019). PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival. Frontiers in Oncology. 9. 189–189. 14 indexed citations

15.

Jia, Yanan, Tingting Qin, Xiaoling Zhang, et al.. (2019). Effect of bevacizumab on the tight junction proteins of vascular endothelial cells.. PubMed. 11(9). 5546–5559. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact